Carla Eugenia Cacho Antonio
YOU?
Author Swipe
A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME) Open
Background: Inflammation is one of the mechanisms involved in heart failure (HF) pathophysiology. Thus, the acute phase reactant protein, orosomucoid, was associated with a worse post-discharge prognosis in de novo acute HF (AHF). However,…
COVID-19 infection impact on cardiovascular and thrombotic events during acute phase and medium-term of the disease Open
Background Coronavirus disease (COVID-19) was labelled a global pandemic in April 2020 by the World Health Organisation. By December of the same year the disease caused by SARS-COV-2, known as COVID-19 (Coronavirus disease 2019), had sprea…
Prognostic impact of treatment with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the acute phase and medium-term on COVID-19 infected patients Open
Introduction The first case of COVID-19 infection was described in Wuhan, China, in December 20191. Shortly after, cases of limited human-to-human transmission were reported in other countries, which made the WHO declare the outbreak a Pub…
View article: The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients
The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients Open
Deterioration is sometimes unexpected in SARS-CoV2 infection. The aim of our study is to establish laboratory predictors of mortality in COVID-19 disease which can help to identify high risk patients. All patients admitted to hospital due …
View article: Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19
Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19 Open
The presence of HD is related to higher mortality. Cardiovascular medications taken before admission are not harmful, statins being protective. The development of cardiovascular events during the course of the disease is related to poor ou…
A New Biomarker Tool for Risk Stratification in “De Novo” Acute Heart Failure (OROME) Open
Background: Inflammation is one of the mechanisms involved on heart failure (HF) pathophysiology. Thus, the acute phase reactant protein, orosomucoid, was associated with a worse post-discharge prognosis in de novo acute HF (AHF). However,…
View article: The COVID-19 Lab Score: An Accurate Dynamic Tool to Predict In-Hospital Outcomes in COVID-19 Patients
The COVID-19 Lab Score: An Accurate Dynamic Tool to Predict In-Hospital Outcomes in COVID-19 Patients Open
Purpose: Deterioration is sometimes unexpected in SARS-CoV2 infection. The aim of our study is to establish laboratory predictors of mortality in COVID-19 disease which can help to identify high risk patients.Methods: All patients admitted…
CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure Open
Our results suggest the role of epicardial fat CD5L as a mediator of AF and its possible paracrine effect by catecholaminergic activity.